NOV:ETR
Novo Nordisk A/S
€ 33.98
arrow_downward
-0.90%(-0.31) Siku 1
14 Okt, 12:13:11 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NOV...
Fungua
€ 33.96
Juu
€ 34.08
Chini
€ 33.90
Mtaji wa soko
128.51B
Wastani wa kiasi cha mauzo
elfu 179.02
Kiasi cha mauzo ya hisa
elfu 31.82
Juu kwa wiki 52
€ 54.87
Chini kwa wiki 52
€ 30.24
Idadi ya wafanyakazi
elfu 67
Fungua
€ 33.96
Juu
€ 34.08
Chini
€ 33.90
Mtaji wa soko
128.51B
Wastani wa kiasi cha mauzo
elfu 179.02
Kiasi cha mauzo ya hisa
elfu 31.82
Juu kwa wiki 52
€ 54.87
Chini kwa wiki 52
€ 30.24
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 4 zilizopita
Novo Nordisk stock pre-market at EUR 33.91
The Motley Fool
·
saa 12 zilizopita
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance
·
saa 13 zilizopita
Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
ad-hoc-news.de
·
saa 22 zilizopita
Citi cuts Novo Nordisk stock target from DKK 310.00 to DKK 296.00
Wasifu
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Kuhusu Novo Nordisk A/S
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 66.7
Lilianzishwa1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Tovutinovonordisk.com